Italy Ran an Innovation Test for Eight Years. Athithi Verma July 28, 2026 Italy graded new medicines full, conditional or not innovative for eight years. The 2025 reform abolished the middle grade, because almost nothing ever graduated. A New Antibiotic Reached a Middle-Income Country Six Months After the US Argentina Just Made One Agency the Buyer for Five National Hospitals Britain Thought It Had an Opt-Out. Washington Reads the Deal Differently. Wet AMDโs Problem Was Never the Drug. It Was the Injections. ADCs Graduated From Salvage to First Line, Twice in a Week Editor’s Pick Britain Thought It Had an Opt-Out. Washington Reads the Deal Differently. One Trial Miss Cut AstraZenecaโs Cushion Above $80bn to $800m White House and London Clinch Drug-Pricing Deal With 25% UK Price LiftNeuroPulse NeuroPulse Wk 30: Three Orexin Programmes in Two Weeks NeuroPulse Wk 29: First Brain Link Shares Movement Between Two PeopleOrphanPulse OrphanPulse Wk 30: CHMP Backs a Drug It Refused Twice OrphanPulse Wk 29: Ionis Takes SMA-Proven Antisense Into Dravet SyndromeDealPulse Signal DealPulse Signal Wk 30: Three Billion-Dollar Deals, No Drugs DealPulse Signal Wk 29: The Biggest Deal of the Week Was a Bare LineDealPulse Report DealFlow H1 2026: M&A Doubles as Upfront Spending Hits $174BThe Beats DealPulse Signal Wk 30: Three Billion-Dollar Deals, No Drugs DealPulse Signal Wk 29: The Biggest Deal of the Week Was a Bare Line DealFlow H1 2026: M&A Doubles as Upfront Spending Hits $174BAnalysis 7 Market Access Trends Reshaping Pharmaย by 2027 The Biologics Patent Cliff: Inside Pharma’s 2026-2029 ReckoningCoverage The ADC Decade Accelerates: What to Watch at ASCO 2026The Briefs Italy Ran an Innovation Test for Eight Years. Athithi Verma July 28, 2026 A New Antibiotic Reached a Middle-Income Country Six Months After the US Athithi Verma July 28, 2026 Argentina Just Made One Agency the Buyer for Five National Hospitals Athithi Verma July 28, 2026 Britain Thought It Had an Opt-Out. Washington Reads the Deal Differently. Athithi Verma July 28, 2026 Wet AMDโs Problem Was Never the Drug. It Was the Injections. Athithi Verma July 27, 2026 ADCs Graduated From Salvage to First Line, Twice in a Week Athithi Verma July 27, 2026 Read More
Italy Ran an Innovation Test for Eight Years. Athithi Verma July 28, 2026 Italy graded new medicines full, conditional or not innovative for eight years. The 2025 reform abolished the middle grade, because almost nothing ever graduated.
Britain Thought It Had an Opt-Out. Washington Reads the Deal Differently. Athithi Verma July 28, 2026